A Simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<record>
<leader>00000nab a2200000 i 4500</leader>
<controlfield tag="001">MAP20071016945</controlfield>
<controlfield tag="003">MAP</controlfield>
<controlfield tag="005">20080418114839.0</controlfield>
<controlfield tag="007">hzruuu---uuuu</controlfield>
<controlfield tag="008">940124e19910501gbr|||| | |00010|eng d</controlfield>
<datafield tag="035" ind1=" " ind2=" ">
<subfield code="a">6800002876</subfield>
</datafield>
<datafield tag="040" ind1=" " ind2=" ">
<subfield code="a">MAP</subfield>
<subfield code="b">spa</subfield>
</datafield>
<datafield tag="084" ind1=" " ind2=" ">
<subfield code="a">873</subfield>
</datafield>
<datafield tag="245" ind1="1" ind2="2">
<subfield code="a">A Simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent</subfield>
<subfield code="c">A. Sato... [et al.]</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">This paper discusses how physiological factors may influence the pharmacokinetic behaviour of inhaled organic solvent vapours, especially in relation to monitoring of biological exposure. To illustrate the discussion a computer based physiological pharmacokinetic model was used describing quantitatively the influence of body size, body fat content, and sex on the pharmacokienetic behaviour of trichloroethylene. Body build (body weight and body fat content), also affected the pharmacokinetic behaviour of this solvent</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080576615</subfield>
<subfield code="a">Medicina laboral</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080605278</subfield>
<subfield code="a">Contaminantes químicos</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080610579</subfield>
<subfield code="a">Enfermedades pulmonares</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080619480</subfield>
<subfield code="a">Enfermedades profesionales</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080554392</subfield>
<subfield code="a">Fisiología</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080600976</subfield>
<subfield code="a">Disolventes orgánicos</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080574215</subfield>
<subfield code="a">Tricloroetileno</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080565541</subfield>
<subfield code="a">Epidemiología</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080583163</subfield>
<subfield code="a">Vapores orgánicos</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080578824</subfield>
<subfield code="a">Análisis clínicos</subfield>
</datafield>
<datafield tag="700" ind1="1" ind2=" ">
<subfield code="0">MAPA20080016975</subfield>
<subfield code="a">Sato, Akio</subfield>
</datafield>
<datafield tag="740" ind1="0" ind2=" ">
<subfield code="a">British journal of industrial medicine</subfield>
</datafield>
<datafield tag="773" ind1="0" ind2=" ">
<subfield code="t">British journal of industrial medicine</subfield>
<subfield code="d">London and Margate</subfield>
<subfield code="g">nº 5, May 1991 ; p. 342-347</subfield>
</datafield>
</record>
</collection>